Under construction – not a live service
Sign in
Taking people in SlovakiaNo phase

Digital coaching program for adults with pre-obesity or obesity

Tests digital, peer and health coaching for adults with obesity.

Plain-language title generated from the registry record
Registry title: DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT

Key facts

Where
Bratislava, SlovakiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 25 and 65 years old?

Source: NCT06983431, who can take part

Where in Slovakia

  • Center for Obesity Management EASO, Biomedical Research Center SASBratislava, SlovakiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Slovak Academy of Sciences
Trial code
NCT06983431
Record updated
21 May 2025
Original description
The principal objective of the project is:Read full original descriptionShow less

DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT IN AT-RISK GROUPS TO IMPROVE HEALTH OUTCOMES THROUGH INTEGRATION OF TECHNOLOGICAL AND SOCIAL INNOVATION

The principal objective of the project is:

* to bring together academic and business research organisations in a joint partnership integrating technological and social innovation, * in order to develop proof-of-concept of a scalable and cost effective personalised digital health program for (pre)obesity patients, * by integrating, in an ethical manner, adaptive AI components aimed at personalisation of the program as well as its cost management, * with the ultimate objective to support sustained behavioural change leading to adoption and internalisation of healthy lifestyle choices.

Inclusion: obesity (BMI 27-42 kg/m²); capacity and willingness to use smartphone; capacity and willingness to use wearables; readiness to change (validated questionaire).

Exclusion: patients using anti-obesity medications who are in the dosage adjustment phase within the last four weeks; diseases that prevent participation in the program, or insufficiently controlled diseases, or terminal-stage illnesses; excessive alcohol consumption or a history of other addictions; patients currently participating in a weight-loss program (commercial, medically supervised, or a research study); patients who are not mentally, physically, or technologically capable of participating; patients who are unable to provide informed consent; patients not adhering to the study protocol.

ClinicalTrials.gov NCT06983431